Pharmacologist Oliver Grundmann on Kratom

Oliver Grundmann, a pharmacologist at the University of Florida, provides insights into his extensive research on the psychoactive plant Kratom. The discussion highlights the importance of gathering scientific data through surveys to better understand user motivations, demographic profiles, and potential public health impacts. These insights are intended to inform regulatory debates and help mitigate risks associated with adulterated or improperly consumed products. Grundmann also touches upon broader pharmacological themes, including the necessity of empirical data in navigating legal challenges and the importance of responsible consumption practices. The conversation serves as an appeal for evidence-based policymaking in the face of evolving public interest.